Please use this identifier to cite or link to this item:
Title: Mutation Spectrum in the Large GTPase Dynamin 2, and Genotype-Phenotype Correlation in Autosomal Dominant Centronuclear Myopathy
Authors: BOEHM, JohannBIANCALANA, ValerieDECHENE, Elizabeth T.BITOUN, MarcPIERSON, Christopher R.SCHAEFER, EliseKARASOY, HaticeDEMPSEY, Melissa A.KLEIN, FabriceDONDAINE, NicolasKRETZ, ChristineHAUMESSER, NicolasPOIRSON, ClaireTOUSSAINT, AnneGREENLEAF, Rebecca S.BARGER, Melissa A.MAHONEY, Lane J.KANG, Peter B.ZANOTELI, EdmarVISSING, JohnWITTING, NannaECHANIZ-LAGUNA, AndoniWALLGREN-PETTERSSON, CarinaDOWLING, JamesMERLINI, LucianoOLDFORS, AndersOUSAGER, Lilian BommeMELKI, JudithKRAUSE, AmandaJERN, ChristinaOLIVEIRA, Acary S. B.PETIT, FlorenceJACQUETTE, AureliaCHAUSSENOT, AnnabelleMOWAT, DavidLEHEUP, BrunoCRISTOFANO, MicheleALDEA, Juan Jose PozaMICHEL, FabriceFURBY, AlainLLONA, Jose E. BarcenaCOSTER, Rudy VanBERTINI, EnricoURTIZBEREA, Jon AndoniDROUIN-GARRAUD, ValerieBEROUD, ChristophePRUDHON, BernardBEDFORD, MelanieMATHEWS, KatherineERBY, Lori A. H.SMITH, Stephen A.ROGGENBUCK, JenniferCROWE, Carol A.SPITALE, Allison BrennanJOHAL, Sheila C.AMATO, Anthony A.DEMMER, Laurie A.JONAS, JessicaDARRAS, Basil T.BIRD, Thomas D.LAURINO, MercyWELT, Selman I.TROTTER, CynthiaGUICHENEY, PascaleDAS, SomaMANDEL, Jean-LouisBEGGS, Alan H.LAPORTE, Jocelyn
Citation: HUMAN MUTATION, v.33, n.6, Special Issue, p.949-959, 2012
Abstract: Centronuclear myopathy (CNM) is a genetically heterogeneous disorder associated with general skeletal muscle weakness, type I fiber predominance and atrophy, and abnormally centralized nuclei. Autosomal dominant CNM is due to mutations in the large GTPase dynamin 2 (DNM2), a mechanochemical enzyme regulating cytoskeleton and membrane trafficking in cells. To date, 40 families with CNM-related DNM2 mutations have been described, and here we report 60 additional families encompassing a broad genotypic and phenotypic spectrum. In total, 18 different mutations are reported in 100 families and our cohort harbors nine known and four new mutations, including the first splice-site mutation. Genotype-phenotype correlation hypotheses are drawn from the published and new data, and allow an efficient screening strategy for molecular diagnosis. In addition to CNM, dissimilar DNM2 mutations are associated with Charcot-Marie-Tooth (CMT) peripheral neuropathy (CMTD1B and CMT2M), suggesting a tissue-specific impact of the mutations. In this study, we discuss the possible clinical overlap of CNM and CMT, and the biological significance of the respective mutations based on the known functions of dynamin 2 and its protein structure. Defects in membrane trafficking due to DNM2 mutations potentially represent a common pathological mechanism in CNM and CMT. Hum Mutat 33: 949-959, 2012. (C) 2012 Wiley Periodicals, Inc.
Appears in Collections:Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/45

Files in This Item:
File Description SizeFormat 
  Restricted Access
publishedVersion (English)615.16 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.